Journal of Molecular Biology
Regular articleDependence on solution conditions of aggregation and amyloid formation by an SH3 domain1
Introduction
Amyloid fibrils are proteinaceous deposits that are associated with a range of human disorders including Alzheimer’s disease and the transmissible spongiform encephalopathies. 1 There is growing evidence that partial or complete unfolding of the specific protein associated with each disease is the first step in the conversion of an otherwise soluble protein into these aggregated structures. 2, 3, 4 Despite the different characteristics of the precursor proteins, all amyloid fibrils are long and unbranched and display a common core cross-β structure 5 suggesting that amyloid formation by the different precursors must share common features. Although considerable advances are being made in the structural characterisation of amyloid fibrils and the underlying mechanism of their formation, 4 many aspects of the process of fibril formation are still not clear. Recently, a range of proteins not related to any human disease have been found to form fibrils in vitro under mildly denaturing conditions. 6, 7, 8, 9, 10 This observation has led to the suggestion that the ability to form amyloid fibrils is a common phenomenon and a generic property of polypeptide chains. 4, 6, 11 The ability to form amyloid fibrils from a wide range of proteins gives access to a large number of model systems with which to study the process of fibril formation in more detail.
One particularly favourable system for investigation of amyloid fibril formation is the SH3 domain of the α-subunit of bovine phosphatidylinositol-3′-kinase (PI3-SH3). Not only is this a protein with a very well defined globular structure, but there is considerable information concerning the structure of the amyloid fibrils that this domain forms readily at acidic pH values. 12, 13 PI3-SH3 is a β-sheet protein 14 that forms a relatively compact denatured state in solution at low pH. 6 The protein slowly aggregates from this state into long fibrils with characteristics closely similar to those of amyloid fibrils associated with human disease. The highly ordered structure of one of the morphologies exhibited by these fibrils has permitted a low-resolution electron density map to be determined by novel cryo-electron microscopy (cryo-EM) techniques. 12 A model of the fibrils constructed to be consistent with this map and with X-ray fibre diffraction data contains four protofilaments, each of which is composed of a pair of β-sheets that is only very slightly twisted around the fibril axis. This map also confirms that the native protein must unfold substantially prior to the assembly of the polypeptide chain into the fundamentally different structure present in the fibrils. 12 Additional studies by EM and atomic force microscopy (AFM) indicate that the protofilaments are wound around each other in a left-handed manner. 13
Despite extensive studies of amyloid fibrils that have resulted in the elucidation of many aspects of their underlying nature, important issues concerning their structure and mechanism of formation still remain to be established. Little is known about the properties of the polypeptide chains in solution prior to assembly into amyloid fibrils or about the molecular details of the conformation of the polypeptide chain within the fibrils. To approach such questions, a detailed analysis of the pH-denaturation profile of PI3-SH3 has been performed in order to link the properties of the soluble precursors with those exhibited by the various aggregated states formed by the protein under different conditions. The results reveal that subtle differences in solution conditions can influence dramatically the ability to form organised fibrils relative to amorphous material, as well as the detailed morphology of the fibrillar structures obtained.
Section snippets
Results
Native PI3-SH3 has been denatured at low pH to study the relationship between the characteristics of the soluble protein, its aggregation kinetics and the nature and degree of organisation of the aggregates it forms, using a variety of biophysical techniques.
Precursor compactness and protein aggregation
The present results indicate that the nature of the aggregates formed by PI3-SH3 is highly dependent on the pH of the solution in which aggregation takes place. NMR spectra of the protein demonstrate that the native structure of the protein is progressively lost at pH values below 4.0 as the protein unfolds. NMR pulse-field gradient experiments show that the effective hydrodynamic radius of the protein increases on unfolding but to a value that is significantly smaller than that of the protein
Conclusions
The results described here confirm that it is necessary to unfold the PI3-SH3 domain in order for it to form stable and ordered aggregates, and ultimately well-defined amyloid fibrils. This conclusion is consistent with existing observations in a range of systems and is indicative of the need for the native structure of soluble proteins to be disrupted to allow the polypeptide chain to associate into β-sheet structures characteristic of amyloid aggregates. 29, 35, 53, 54 Aggregation of the
Protein expression and purification
PI3-SH3 was expressed in Escherichia coli BL21 strain, and purified as described. 57 The protein was also expressed in E. coli BL21 (DE3) strain as a fusion with a (histidine)6-tag at the N terminus using the vector pET14b (Novagen, Madison, WI). The fusion protein was passed through a metal-chelate resin (Poros, Applied Biosystems, Foster City, CA) pre-loaded with Ni2+, and eluted with a gradient of 5 mM–250 mM imidazole in 50 mM sodium phosphate buffer (pH 7.0), 0.5 M NaCl. The eluted protein
Acknowledgements
We thank Dr Deborah Wilkins and Dr Jonathan Jones for assistance with the NMR diffusion measurements, and Dr Mario Bouchard for helpful discussions. J.Z. was supported by grants from the European Commission (EC) and the Wellcome Trust. I.G. acknowledges a grant from the EC. J.L.J. was supported by a grant of the Wellcome Trust. The research of C.M.D. is supported, in part, by a programme grant from the Wellcome Trust. The Oxford Centre for Molecular Sciences is supported by the UK BBSRC, MRC
References (60)
The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways
Curr. Opin. Struct. Biol.
(1998)- et al.
Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module
J. Mol. Biol.
(1998) Protein misfolding, evolution and disease
Trends Biochem. Sci.
(1999)- et al.
Ultrastructural organization of amyloid fibrils by atomic force microscopy
Biophys. J.
(2000) - et al.
Solution structure and ligand-binding site of the SH3 domain of the p85 α-subunit of phosphatidylinositol 3-kinase
Cell
(1993) Protein denaturation
Advan. Protein Chem.
(1968)- et al.
Acid-induced folding of heme proteins
Methods Enzymol.
(1994) - et al.
Vibrational spectroscopy and conformation of peptides, polypeptides, and proteins
Advan. Protein Chem.
(1986) - et al.
Similarities between the spectrin SH3 domain denatured state and its folding transition state
J. Mol. Biol.
(2000) - et al.
Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants
J. Struct. Biol.
(2000)
Observation of metastable Aβ amyloid protofibrils by atomic force microscopy
Chem. Biol.
Amyloid β-protein fibrillogenesis. Detection of a protofibrillar intermediate
J. Biol. Chem.
Amyloid β-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates
J. Biol. Chem.
The toxicity of the Alzheimer’s β-amyloid peptide correlates with a distinct fiber morphology
J. Struct. Biol.
Watching amyloid fibrils grow by time-lapse atomic force microscopy
J. Mol. Biol.
Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin
J. Struct. Biol.
Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties
J. Mol. Biol.
Fibrillar Alzheimer’s amyloid peptide Aβ(1-42) stimulates low density lipoprotein binding and cell association, free radical production and cell cytotoxicity in PC12 cells
Neuropeptides
Specificity of abnormal assembly in immunoglobulin light chain deposition disease and amyloidosis
J. Mol. Biol.
Alternative conformations of amyloidogenic proteins govern their behavior
Curr. Opin. Struct. Biol.
The high resolution crystal structure of deoxyhemoglobin S
J. Mol. Biol.
Head-to-tail and side-by-side oligomerization of human carbonic anhydrase IIa small angle X-ray scattering study
Int. J. Biol. Macromol.
Folding kinetics of the SH3 domain of PI3 kinase by real-time NMR combined with optical spectroscopy
J. Mol. Biol.
Amyloidosis
Histopathology
Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis
Nature
The structural basis of protein folding and its links with human disease
Phil. Trans. Roy. Soc. London
From the globular to the fibrous stateprotein structure and structural conversion in amyloid formation
Quart. Rev. Biophys.
Amyloid fibril formation by an SH3 domain
Proc. Natl Acad. Sci. USA
Designing conditions for in vitro formation of amyloid protofilaments and fibrils
Proc. Natl Acad. Sci. USA
Protein engineering as a strategy to avoid formation of amyloid fibrils
Protein Sci.
Cited by (203)
Structural insights and aggregation propensity of a super-stable monellin mutant: A new potential building block for protein-based nanostructured materials
2024, International Journal of Biological MacromoleculesInhibition of lysozyme amyloid fibrillation by curcumin-conjugated silver nanoparticles: A multispectroscopic molecular level study
2023, Journal of Molecular LiquidsAdsorption of lysozyme on gold surfaces in the presence of an external electric potential
2021, BioelectrochemistryChallenges in sample preparation and structure determination of amyloids by cryo-EM
2021, Journal of Biological ChemistryThermodynamics of amyloid fibril formation from non-equilibrium experiments of growth and dissociation
2021, Biophysical ChemistryMolecular mechanisms of amyloid aggregation in human proteinopathies
2020, Protein Homeostasis Diseases: Mechanisms and Novel Therapies
- 1
Edited by P. E. Wright
- 2
Present addresses: J. L. Jiménez, Computational Genome Analysis Laboratory, Imperial Cancer Research Fund, 44 Lincoln’s Inn Fields, London WC2A 3PX, UK; Christopher M. Dobson, Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK.